Apply emerging clinical data on novel systemic therapies—including immunotherapies, antibody-drug conjugates, and PARP inhibitors—to treatment strategies for patients with GI, GU, lung, and breast cancers.

Interpret molecular and biomarker testing results (e.g., HER2, FGFR, RET, BRAF, KRAS) to guide therapeutic selection and personalize oncology care.

Evaluate the safety profiles and mechanisms of action of newly approved agents and investigational treatments and integrate this knowledge into patient counseling and monitoring strategies.

Assess the role of multidisciplinary collaboration in managing complex cancer cases through tumor board participation and interprofessional planning.

Describe the design and goals of ongoing clinical trials, and identify patients who may be appropriate candidates for enrollment based on disease characteristics and therapeutic needs.